Approvals/NMPA/Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

Approved

生物制品

Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

甘李药业股份有限公司🇨🇳 National Medical Products Administration

Approval Id: ecf995ea6b1c1958
Approval Number: 国药准字S20227015
Generic Name: 精蛋白锌重组赖脯胰岛素混合注射液(25R)
Generic Name En: Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 3ml:300单位(预填充注射笔)
Reg Date: 2024-03-26
Company Name: 甘李药业股份有限公司
Company Address: 北京市通州区漷县镇南凤西一路8号
Production Company Name: 甘李药业股份有限公司
Production Company Address: 北京市通州区漷县镇南凤西一路8号
Company Detail Path: /organization/gan-and-lee-pharmaceuticals-co-ltd
Production Company Detail Path: /organization/gan-and-lee-pharmaceuticals-co-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 26, 2024

Approval ID

ecf995ea6b1c1958

Type

生物制品